A Case report about clinical outcome of a 37-week pregnant woman with COVID-19 in Bangladesh | ||||
Microbes and Infectious Diseases | ||||
Article 5, Volume 1, Issue 3, November 2020, Page 96-99 PDF (230.92 K) | ||||
Document Type: Short Reports (case reports) | ||||
DOI: 10.21608/mid.2020.34734.1031 | ||||
View on SCiNiTO | ||||
Authors | ||||
Arifa Akram 1; Md Shahin Jewel2; Md Haque3; Lubana Akram4 | ||||
1Department of virology, National Institute of laboratory medicine and referral center, Dhaka, Bangladesh. | ||||
2National Institute of Preventive and Social Medicine (NIPSOM), Dhaka, Bangladesh | ||||
3Sheikh Hasina National Institute of Burn & plastic Surgery, Dhaka, Bangladesh | ||||
4Resident Paediatric Gastroenterology Deputed to BSMMU, Dhaka, Bangladesh | ||||
Abstract | ||||
Background: A highly pathogenic coronavirus named SARS‐CoV‐2 emerged in December 2019 in Wuhan, China after Severe Acute Respiratory Syndrome coronavirus (SARS‐CoV) and Middle East Respiratory Syndrome coronavirus (MERS‐CoV). It spreads rapidly around the world. Pregnant women are at risk for COVID-19 which is more likely to have complications and even progress to severe illness. There is not enough data to determine the effect of COVID-19 infection on the fetus. Case report: We report a case of 37-week pregnant woman with COVID-19 infection in Bangladesh who delivered an infant with no evidence of COVID-19 by RT-PCR. Careful transmission precautions with the infant, including contact, droplet, and airborne precautions helps us to deliver a negative baby. Conclusion: This case provides an initial view of the outcome associated with pregnancy-related COVID-19 and several effective strategies for managing pregnant women with COVID-19. Although SARS-CoV-2 may increase health risks to both mothers and infants during pregnancy, intensive attention should be paid to pregnant patients. | ||||
Keywords | ||||
SARS-CoV-2; pregnant woman; COVID 19, clinical features | ||||
Statistics Article View: 498 PDF Download: 368 |
||||